Epinephrine Market Scope And Analysis

  • Report Code : TIPRE00003412
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Epinephrine Market Scope, Analysis, and Trends by 2031

Buy Now

Epinephrine Market Report Epinephrine Market Size and Share Epinephrine Market Scope and Analysis

Epinephrine Market Report Scope

Report Attribute Details
Market size in 2021 US$ 2.63 Billion
Market Size by 2031 US$ 5.85 Billion
Global CAGR (2023 - 2031) 8.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Prefilled Syringes
  • Auto-Injectors
  • Ampoules
  • Vials
By Application
  • Anaphylaxis
  • Superficial Bleeding
  • Respiratory Disorders
  • Cardiac Arrest
By Distribution Channel
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • MYLAN N V
  • Abbott
  • ALK ABELLO
  • Amneal Pharma
  • Kaleo
  • LINCOLN MEDICAL LTD BioProject
  • Teva Pharmaceuticals Ltd
  • Adamis Pharmaceuticals Corporation Novartis AG
  • Emirade
    		•

    Epinephrine Market News and Recent Developments

    The epinephrine market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for epinephrine and strategies:

    • In March 2024, Aquestive Therapeutics, Inc., a pharmaceutical company focused on advancing medicines released positive topline clinical data from its Phase 3 pivotal pharmacokinetic (PK) clinical study of Anaphylm™ (epinephrine) Sublingual Film.  (Source: Company Press Release)
    • In December 2023, Nasus Pharma announced its additional phase 2 study (NP-006-Epinephrine) confirming the superiority and safety of its lead FMXIN002 Intranasal Epinephrine product.  (Source: Company Press Release)

    Epinephrine Market Report Coverage and Deliverables

    The “Epinephrine Market Size and Forecast (2022–2030)” report provides a detailed analysis of the market covering below areas:

    • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Market dynamics such as drivers, restraints, and key opportunities
    • Key future trends
    • Detailed PEST and SWOT analysis
    • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
    • Detailed company profiles